Dr Riechelmann speaks with ecancertv at ESMO 2016 about carcinoid syndrome, which results from carcinoid tumour invasion of organ sites and stimulation of the release of hormones.

She describes the symptoms and impacts of carcinoid syndrome on patients quality of life, and introduces her review of current literature into understanding of the disease.

Dr Riechelmann calls for studies into the mechanistic action and incidence of carcinoid syndrome, rather than relying on retrospective analyses.

Read Dr Riechelmann’s article "Complications from carcinoid syndrome: review of the current evidence" here